Maintaining a safe blood supply in an era of emerging pathogens

Journal of Infectious Diseases

Volumn 213, Issue 11, 2016, Pages 1676-1677

  Marks, Peter W ^a   Epstein, Jay S ^a   Borio, Luciana L ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Blood safety; Donor screening tests; Emerging pathogens; Pathogen reduction; Zika virus

Indexed keywords

VIRUS RNA;

BLOOD ANALYSIS; BLOOD DONOR; BLOOD SAFETY; BLOOD SAMPLING; BLOOD TRANSFUSION; FOOD AND DRUG ADMINISTRATION; HUMAN; NONHUMAN; NUCLEIC ACID ANALYSIS; PATHOGEN REDUCTION SYSTEM; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SCREENING TEST; SEXUAL TRANSMISSION; UNITED STATES; VIRUS TRANSMISSION; ZIKA FEVER; ADVERSE EFFECTS; BLOOD; BLOOD BANK; BLOOD STORAGE; COMMUNICABLE DISEASE; STANDARDS; TRANSMISSION; VIROLOGY; ZIKA VIRUS;

BLOOD BANKS; BLOOD DONORS; BLOOD PRESERVATION; BLOOD TRANSFUSION; COMMUNICABLE DISEASES, EMERGING; HUMANS; UNITED STATES; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 84977647599     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw089     Document Type: Review

References (13)

1. Zanluca C, de Melo VC, Mosimann AL, et al. First report of autochthonous transmission of Zika virus in Brazil. Mem Inst Oswaldo Cruz 2015; 110:569-72.
2. Grard G, Caron M, Mombo IM, et al. Zika virus in Gabon (Central Africa)-2007: a new threat from Aedes albopictus? PLoS Negl Trop Dis 2014; 8: e2681.
3. Hayes EB. Zika virus outside Africa. Emerg Infect Dis 2009; 15:1347-50.
4. Duffy MR, Chen TH, Hancock WT, et al. Zika Virus Outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 2009; 360:2536-43.
5. Centers for Disease Control and Prevention. Areas with Zika: countries and territories with active Zika virus transmission. http://www.cdc.gov/zika/geo/index.html. Accessed 8 March 2016.
6. Petersen E,Wilson ME, Touch S, et al. Rapid spread of Zika virus in the Americas-implications for public health preparedness for mass gatherings at the 2016 Brazil Olympic Games. Int J Infect Dis 2016; 44:11-5.
7. Musso D, Roche C, Robin E, et al. Potential sexual transmission of Zika virus. Emerg Infect Dis 2015; 21:359-61.
8. Aubry M, Finke J, Teissier A, et al. Seroprevalence of arboviruses among blood donors in French Polynesia, 2011-2013. Int J Infect Dis 2015; 41:11-2.
9. Hills SL, Russell K, Hennessey M, et al. Transmission of Zika virus through sexual contact with travelers to areas of ongoing transmission-continental United States, 2016. MMWR Morb Mortal Wkly Rep 2016; 65:215-6.
10. Food and Drug Administration. Recommendations for donor screening, deferral, and product management to reduce the risk of transfusion-transmission of Zika Virus. http://www.fda.gov/downloads/Biologics BloodVaccines/GuidanceComplianceRegulatory Information/Guidances/Blood/UCM486360.pdf. Accessed 1 March 2016.
11. Freedman J. Transfusion-whence and why. Transfus Apher Sci 2014; 50:5-9.
12. Hogshire L, Carson JL. Red blood cell transfusion: what is the evidence when to transfuse? Curr Opin Hematol 2013; 20:546-51.
13. Salunkhe V, van der Meer PF, de Korte D, Seghatchian J, Gutiérrez L. Development of blood transfusion product pathogen reduction treatments: a review of methods, current applications and demands. Transfus Apher Sci 2015; 52:19-34.